الصفحة الرئيسية>>Signaling Pathways>> Apoptosis>>RH01386

RH01386

رقم الكتالوجGC70570

RH01386 هو جزيء صغير يمكن أن يمنع خلل خلايا β الناتج عن إجهاد الشبكة الإندوبلازمية والموت، ويمنع التعبير الجيني proapoptotic.

Products are for research use only. Not for human use. We do not sell to patients.

RH01386 التركيب الكيميائي

Cas No.: 301177-36-6

الحجم السعر المخزون الكميّة
10mM (in 1mL DMSO)
250٫00
متوفر
1 mg
117٫00
متوفر
5 mg
261٫00
متوفر
10 mg
378٫00
متوفر
25 mg
612٫00
متوفر
50 mg
837٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents
RH01386 is a small molecule that can prevent endoplasmic reticulum stress (ERS)-induced β cell dysfunction and death, and inhibits proapoptotic gene expression. RH01386 restores ERS-impaired glucose-stimulated insulin secretion responses. RH01386 has the potential for type 2 diabetes treatment.

RH01386 (270 nM-70 μM; 72 hours) is confirmed to increase ATP levels in βTC6 cells treated with (tunicamycin) Tm, exhibits a EC50 value of 1.894 μM[1].
RH01386 (270 nM-70 μM; 72 hours) dose-dependently inhibits (tunicamycin) Tm-induced cell death, and inhibits the activity of caspase-3, a downstream effector of the apoptotic pathway in βTC6 cells[1].

References:
[1]. Tran K, et al. Identification of small molecules that protect pancreatic β cells against endoplasmic reticulum stress-induced cell death.ACS Chem Biol. 2014 Dec 19;9(12):2796-806.

مراجعات

Review for RH01386

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for RH01386

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.